MiR-10a-5p suppresses hepatocellular carcinoma progression and microvascular invasion by targeting TFR1-STAT3-CD24 signaling axis
Our findings reveal miR-10a-5p as a key regulator of HCC progression and MVI, operating through a novel pathway involving TFR1, STAT3, and CD24. This study provides new insights into the molecular mechanisms of CT features and highlights potential therapeutic targets for HCC treatment.
Authors
- Xiaoyue Nong
- Rulin Xu
- Yupeng Zhang
- Wei Zhang
- Yingying Chen
- Tao Bai
- Di Lai
- Ziyi Wang
Institutions
- Canon (Japan) (JP)
- Guangxi Medical University (CN)
- Liuzhou General Hospital (CN)
- Fourth Affiliated Hospital of Guangxi Medical University (CN)
- Tumor Hospital of Guangxi Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-01-02
- DOI
- https://doi.org/10.3389/fonc.2025.1694441
- Primary Topic
- MicroRNA in disease regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00